144 related articles for article (PubMed ID: 17133109)
21. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors.
Bilimoria KY; Bentrem DJ; Merkow RP; Tomlinson JS; Stewart AK; Ko CY; Talamonti MS
J Am Coll Surg; 2007 Oct; 205(4):558-63. PubMed ID: 17903729
[TBL] [Abstract][Full Text] [Related]
22. Reversible night blindness in a patient with neuroendocrine tumour of pancreas.
Appaswamy S; De Silva D; Tyagi A; Grocott LE; Heath PD; Gillow T
Eye (Lond); 2005 Jun; 19(6):720-2. PubMed ID: 15359255
[No Abstract] [Full Text] [Related]
23. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
Starker LF; Carling T
Curr Opin Oncol; 2009 Jan; 21(1):29-33. PubMed ID: 19125015
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary neuroendocrine/carcinoid tumors: a review article.
Bertino EM; Confer PD; Colonna JE; Ross P; Otterson GA
Cancer; 2009 Oct; 115(19):4434-41. PubMed ID: 19562772
[TBL] [Abstract][Full Text] [Related]
25. From basic to clinical research in gastroenteropancreatic neuroendocrine tumor disease -- the clinician-scientist perspective.
Wiedenmann B; Pape UF
Neuroendocrinology; 2004; 80 Suppl 1():94-8. PubMed ID: 15477725
[TBL] [Abstract][Full Text] [Related]
26. Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms.
Cho CS; Labow DM; Tang L; Klimstra DS; Loeffler AG; Leverson GE; Fong Y; Jarnagin WR; D'Angelica MI; Weber SM; Blumgart LH; Dematteo RP
Cancer; 2008 Jul; 113(1):126-34. PubMed ID: 18457323
[TBL] [Abstract][Full Text] [Related]
27. Endoscopic evaluation and palliation of pancreatic adenocarcinoma: current and future options.
Pausawasdi N; Scheiman J
Curr Opin Gastroenterol; 2007 Sep; 23(5):515-21. PubMed ID: 17762557
[TBL] [Abstract][Full Text] [Related]
28. Neuroendocrine tumors of the diffuse neuroendocrine system.
Gustafsson BI; Kidd M; Modlin IM
Curr Opin Oncol; 2008 Jan; 20(1):1-12. PubMed ID: 18043250
[TBL] [Abstract][Full Text] [Related]
29. [Gastrointestinal neuroendocrine tumors].
Bornschein J; Kidd M; Malfertheiner P; Modlin IM
Dtsch Med Wochenschr; 2008 Jul; 133(28-29):1505-10. PubMed ID: 18597210
[TBL] [Abstract][Full Text] [Related]
30. CT findings of non-functioning neuroendocrine pancreatic tumors.
Secil M; Goktay AY; Oksuzler Y; Sagol O; Dicle O; Igci E; Pirnar T
Comput Med Imaging Graph; 2002; 26(1):43-5. PubMed ID: 11734373
[TBL] [Abstract][Full Text] [Related]
31. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: pre- and perioperative therapy in patients with neuroendocrine tumors.
Akerström G; Falconi M; Kianmanesh R; Ruszniewski P; Plöckinger U; ;
Neuroendocrinology; 2009; 90(2):203-8. PubMed ID: 19713712
[No Abstract] [Full Text] [Related]
32. Management of neuroendocrine tumors: a meeting of experts from Latin America.
Costa F; Domenichini E; Garavito G; Medrano R; Mendez G; O'Connor J; Rojas W; Torres S; Younes RN; Delle Fave G; Oberg K
Neuroendocrinology; 2008; 88(3):235-42. PubMed ID: 18663282
[TBL] [Abstract][Full Text] [Related]
33. Acinar cell carcinoma of the pancreas: is the absence of neuroendocrine component related to a more malignant behavior?
Machado MC; Machado MA; Perini MV; Herman P; Jukemura J; Leite KR; Bacchella T
Hepatogastroenterology; 2008; 55(82-83):708-10. PubMed ID: 18613439
[TBL] [Abstract][Full Text] [Related]
34. The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.
Chambers AJ; Pasieka JL; Dixon E; Rorstad O
Surgery; 2008 Oct; 144(4):645-51; discussion 651-3. PubMed ID: 18847650
[TBL] [Abstract][Full Text] [Related]
35. Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable?
Teh SH; Deveney C; Sheppard BC
Am J Surg; 2007 May; 193(5):610-3; discussion 613. PubMed ID: 17434366
[TBL] [Abstract][Full Text] [Related]
36. Diffuse pancreatic serous cystadenoma associated with neuroendocrine carcinoma: a case report and review of literature.
Agarwal N; Kumar S; Dass J; Arora VK; Rathi V
JOP; 2009 Jan; 10(1):55-8. PubMed ID: 19129617
[TBL] [Abstract][Full Text] [Related]
37. Well or poorly differentiated nonfunctioning neuroendocrine carcinoma of the pancreas: a single institution experience with 17 cases.
Sellner F; Sobhian B; De Santis M; Pont J; Staettner S; Sellner S; Karner J; Klimpfinger M
Eur J Surg Oncol; 2008 Feb; 34(2):191-5. PubMed ID: 17475440
[TBL] [Abstract][Full Text] [Related]
38. Preclinical evaluation of the alpha-particle generator nuclide 225Ac for somatostatin receptor radiotherapy of neuroendocrine tumors.
Miederer M; Henriksen G; Alke A; Mossbrugger I; Quintanilla-Martinez L; Senekowitsch-Schmidtke R; Essler M
Clin Cancer Res; 2008 Jun; 14(11):3555-61. PubMed ID: 18519789
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic neuroendocrine tumors: the impact of surgical resection on survival.
Hill JS; McPhee JT; McDade TP; Zhou Z; Sullivan ME; Whalen GF; Tseng JF
Cancer; 2009 Feb; 115(4):741-51. PubMed ID: 19130464
[TBL] [Abstract][Full Text] [Related]
40. Synchronous epithelial and neuroendocrine cancers of the pancreas: case series of a rare occurrence.
Power DG; Shia J; Allen PJ; Jarnagin WR; O'Reilly EM
Clin Colorectal Cancer; 2011 Jun; 10(2):146-50. PubMed ID: 21859569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
